NP5

GER · Equity

Newron Pharmaceuticals S.p.A.

DE Healthcare Biotechnology

Latest week
29 May 2026
Close
15.150000
Fair value
10.376090
Expectation
Undecided 48.40%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
15.15
12-Week Change
-19.93%
Trend Signal
Inactive
Expectation
Undecided 48.40%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-6.10
Market Dynamics
-1.26

Over the latest 12 completed weeks ending 2026-05-29, NP5 fell 19.93%, moving from 18.92 to 15.15. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -6.10 and has softened across the 12-week window. Market Dynamics is -1.26 on the latest week. Expectation is undecided at 48.40%.